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Original ArticleHuman metabolomics reveal daily variations
under nutritional challenges speciﬁc to serum
and skeletal muscleShogo Sato 1,4, Evelyn B. Parr 2,4, Brooke L. Devlin 2, John A. Hawley 2,*, Paolo Sassone-Corsi 1,3,**ABSTRACT
Objective: Advances in the ﬁeld of metabolomics and the concomitant development of bioinformatics tools constitute a promising avenue
towards the development of precision medicine and personalized proﬁling for numerous disease states. Studies in animal models have
strengthened this concept, but the application in human subjects is scarce.
Methods: Utilizing high-throughput metabolomics, we have analyzed the metabolome levels of human serum and skeletal muscle in the morning
and evening in response to divergent nutritional challenges in order to identify unique signatures present in serum and muscle.
Results: We reveal dynamic daily variation of human metabolome unique to serum and muscle. The overall effect of nutritional challenges on the
serum and muscle metabolome results in a profound rewiring of morning-evening metabolic proﬁles in human participants in response to the
timing and type of dietary challenge.
Conclusion: We highlight time-of-day and meal-composition dependence of reprogramming of human metabolome by nutritional challenges.
 2018 The Authors. Published by Elsevier GmbH. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Keywords Circadian clock; Human; Serum metabolome; Skeletal muscle metabolome; High fat diet; High carbohydrate diet1. INTRODUCTION
During the past decades, clinical chemistry has contemplated only a
limited number of small metabolites such as glucose, cholesterol,
creatinine and urea to evaluate an individual’s health proﬁle [1]. It is
becoming clear that ﬁngerprinting by metabolomics will play a greater
role in tracking and diagnosing an individual’s health status as it
provides a direct functional read-out of the physiological status of an
organism and a comprehensive analysis of low-molecular weight
compounds in biological samples such as cells, body ﬂuids and tissues
[2,3]. Recent technological advances, such as metabolomics measures
through liquid-chromatography mass spectrometry (LC-MS) along with
the subsequent development of sophisticated bioinformatics tools,
have been valuable in unraveling the complexity and speciﬁcity of1Center for Epigenetics and Metabolism, Department of Biological Chemistry, INSERM U
Research Program, Mary MacKillop Institute for Health Research, Australian Catholic Uni
of Medicine, 324 Sprague Hall, University of California, Irvine, USA
4 Shogo Sato and Evelyn B. Parr contributed equally to this work.
*Corresponding author. Exercise and Nutrition Research Program, Mary MacKillop Ins
Melbourne, VIC, 3000, Australia. E-mail: john.hawley@acu.edu.au (J.A. Hawley).
**Corresponding author. Center for Epigenetics and Metabolism, Department of Biolog
CA, 92697, USA. E-mail: psc@uci.edu (P. Sassone-Corsi).
Abbreviations: 18S rRNA, 18S ribosomal RNA; ANOVA, analysis of variance; BHBA, b-
CHO, carbohydrate; Dbp, D-box binding PAR bZIP transcription factor; EDTA, ethylen
discovery rate; GCeMS, gas chromatographyemass spectrometry; HFD, high fat diet
Ppard, peroxisome proliferator-activated receptor-delta; Ppargc1a, peroxisome prolife
lymerase chain reaction; PCA, principal component analysis; Pdk4, pyruvate dehydroge
resting metabolic rate; SCN, suprachiasmatic nucleus; TEI, total energy intake; UPLC-
Received May 5, 2018  Revision received June 5, 2018  Accepted June 8, 2018 
https://doi.org/10.1016/j.molmet.2018.06.008
MOLECULAR METABOLISM 16 (2018) 1e11  2018 The Authors. Published by Elsevier GmbH. This is an open acc
www.molecularmetabolism.commetabolic changes in a number of mouse and human tissues, as well
blood and saliva [4,5]. These approaches are especially useful in pa-
thology, as metabolomics is well suited to identify and deliver bio-
markers for a variety of clinical conditions [1]. The identiﬁcation of
speciﬁc metabolomics ‘signatures’ in response to challenges such as a
high fat diet (HFD), exercise, drugs of abuse or distinctive of diseases is
of utmost importance to guide the discovery of diagnostic and
mechanistic biochemical biomarkers that monitor perturbations to
individual metabolic homeostasis [6e8]. In this context, circadian
rhythms have emerged as essential in the control of daily metabolic
cycles [9]. Revealing how the time-of-the-day affects variations in an
individual’s metabolic state provides a robust tool to explore metab-
olomics signatures that are speciﬁc for a time of day or night, as well
as the effect of the timing of meals, exercise and other ‘zeitgebers’.1233, School of Medicine, University of California, Irvine, USA 2Exercise and Nutrition
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titute for Health Research, Australian Catholic University, 215 Spring St., Level 5,
ical Chemistry, School of Medicine, University of California, 324 Sprague Hall, Irvine,
hydroxybutyric acid; BMI, body mass index; Bmal1, brain and muscle ARNT-Like 1;
ediaminetetraacetic acid; ELISA, enzyme-linked immunosorbent assay; FDR, false
; HCD, high-carbohydrate diet; LC-MS, liquid-chromatography mass spectrometry;
rator-activated receptor gamma coactivator 1-alpha; HK2, hexokinase 2; PCR, po-
nase kinase 4; Pdp1, pyruvate dehyrogenase phosphatase catalytic subunit 1; RMR,
MS/MS, ultra-high performance liquid chromatography-tandem mass spectrometry
Available online 18 June 2018
ess article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). 1
Figure 1: Reprogramming of the daily variation of serum metabolome in human participants by nutritional challenges. (A) Number of serum metabolites affected by diet or time. (B)
Separation of samples based on the timing of the collection of serum by PCA. (C) Heatmaps display signiﬁcantly gradient serum metabolites exclusively in pre- (left panel) and post-HFD
(middle panel), and in both pre- and post-HFD (right panel). (D) Pie chart shows the number and ratio of signiﬁcantly gradient metabolites in the serum under HFD condition. Numbers within
the pie chart indicate number of gradient metabolites. Gradient, metabolites signiﬁcantly different between morning and evening, Morning, metabolites being signiﬁcantly higher in the
morning, and Evening,metabolites being signiﬁcantly higher in the evening. (E) Heatmaps display gradient serummetabolites exclusively in pre- (left panel) and post-HCD (middle panel), and
in both pre- and post-HCD (right panel). (F) Pie chart exhibits the number of gradientmetabolites in the serumunder HCD treatment. (G) Volcano plot exhibits the signiﬁcance of gradient serum
metabolites under pre- (open circle) and post- (closed circle) HFD condition. The x-axis and y-axis represent the fold change (evening/morning) and signiﬁcance of gradient serum me-
tabolites, respectively. (H) Top 3 gradient serum metabolites unique to pre-HFD (top) and post-HFD (bottom). *** indicates P < 0.001 between morning and evening, x and xx indicate
P< 0.05 and P< 0.01 between pre and post in the morning, yy and yyy indicate P< 0.01 and P< 0.001 between pre and post in the evening. (I) Volcano plot exhibits the signiﬁcance of
gradient serummetabolites under pre- (open circle) and post- (closed circle) HCD condition. (J) Top 3gradient serummetabolites unique to pre-HCD (top) and post-HCD (bottom). *** indicates
P< 0.001 betweenmorning and evening, x and xxx indicate P< 0.05 and P< 0.001 between pre and post in the morning, y, yy, yyy indicate P< 0.05, P< 0.01 and P< 0.001 between
pre and post in the evening. (K) Histogram shows the biological classiﬁcation of gradient metabolites in the serum under HFD (left) and HCD (right) conditions. Orange and blue bars indicate
the number of metabolites being higher in the morning and evening, respectively, within each classiﬁcation. Two-way ANOVA compares the mean differences of metabolites levels between
morning and evening. Adjusted p-value cutoff of 0.05 was used. N ¼ 8 biological replicates in each time of day were subjected to the metabolomics analysis.
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Circadian rhythms govern a large variety of behavioral, physiological
and metabolic processes, with a large fraction of mammalian meta-
bolism undergoing circadian oscillations [10]. Such a notion is critical,
as it raises awareness for increased consideration regarding the time
of monitoring clinically relevant biomarkers in patient and other pop-
ulations. Indeed, studies in humans show signiﬁcant oscillations in the
levels of key biomarkers, possibly leading to misleading readouts that
may result in incorrect therapeutic outcomes [3e5,11]. The human
body comprises a series of circadian feedforward and feedback loops
with cross-talks between tissues and organs. However, sampling of
muscle, adipose tissue, liver and other tissues is highly invasive and
prohibitive in the majority of cases. Accordingly, a comparative anal-
ysis of the circadian metabolome in the serum versus peripheral tis-
sues (i.e., skeletal muscle) is critical to decipher circulating metabolites
that constitute speciﬁc signatures associated with a given physiolog-
ical state. In this context, human interventions remain scarce [12], and
to date, there are no studies that have simultaneously measured
metabolomics both serum and a peripheral tissue in humans.
Analyses of the serum metabolome in humans and mice have been
performed under a variety of conditions. Davies et al. [13] studied the
effect of sleep deprivation on the human plasma metabolome,
revealing the implication of sleep/wake cycle with human metabolism.
A more recent study describes the distinct link of gut microbiome to
serum metabolome between lean and obese individuals [7]. However,
it has been suggested that a ‘disrupted’ circadian rhythm as a result of
dietary intake patterns is linked with metabolic diseases associated
with obesity. In turn, obesity is fueled by inactivity and sedentary
behavior, and has been highly related to detrimental glucose proﬁles
(i.e. development of type 2 diabetes). Research in rodent models has
shown the detrimental effect of a high-fat, low carbohydrate diet on
glucose regulation and weight management [14]. Indeed, the majority
of the studies demonstrating the intimate interplay between the
circadian clock and cellular metabolism have used animal models
[15e19], likely due to the ease of sampling of muscle, adipose tissue,
liver and other tissues. To date, there are few studies in humans to
assess the effects of a HFD on metabolic measures in the skeletal
muscle.
As serum is the biological sample most easily obtained in human
participants, as well as a critical link between peripheral tissues and
the brain, we explored how the consumption of a HFD compared to a
high-carbohydrate diet (HCD) affects the levels of both serum and
skeletal muscle metabolites of humans in a time-of-day speciﬁc
manner. A comparative analysis of the circadian metabolome in the
serum versus peripheral tissues (i.e., skeletal muscle) is critical to
decipher the circulating metabolites that constitute speciﬁc signatures
associated with any given physiological state. Here we present the ﬁrst
comparative analysis of the metabolome at different time of day in the
muscle and serum of human participants under nutritional challenges.
2. MATERIALS AND METHODS
2.1. Experimental model and subject details
As previously reported [20], overweight/obese (body mass index (BMI)
27e32.5 kg/m2) men (aged 30e45 yr) following a sedentary lifestyle
(<150 min/wk exercise and >3 h/d sitting) were recruited to partic-
ipate. The study was approved by the Human Research Ethics Com-
mittee of the Australian Catholic University (2016e77H) and registered
with the Australian New Zealand Clinical Trials Registry
(ACTRN12616000637448). All participants provided written informed
consent and completed two experimental conditions in a randomized,
crossover design with a 7 day wash out period between conditions.MOLECULAR METABOLISM 16 (2018) 1e11  2018 The Authors. Published by Elsevier GmbH. This is an open acc
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study employed two experimental dietary conditions for 5-d, each
following a 7-d habitual period where participants were monitored for
dietary intake and physical activity patterns. The dietary conditions
were A) a high fat, low carbohydrate diet (HFD) consisting of 65% total
energy intake (TEI) from fat, 15% TEI from carbohydrate (CHO) and
20% TEI from protein and B) an isoenergetic high carbohydrate, low fat
diet (HCD) consisting of 65% TEI from CHO, 15% TEI from fat and 20%
TEI from protein. Skeletal muscle biopsies and blood samples were
obtained in a fasted state in the morning (0730 h) and following dinner
in the evening (1930 h) on Day 0 (end of habitual baseline period) and
Day 5 of each experimental dietary condition, to compare the diet
intervention to baseline and assess individual variability.
2.2. Method details
2.2.1. Study protocol
At the beginning of the habitual period, participants attended the
laboratory (Day 7) for baseline measures prior to a 7-d ‘habitual’
recording period. On Day 0, participants arrived at 0630 h after an
overnight fast and a single forearm venipuncture was performed to
collect of blood (5 mL Serum clot activator; 6 mL EDTA; Vacuette). The
serum samples at room temperature for 30 min before centrifuging at
3000 g, for 10 min at 4 C, while the plasma (EDTA) sample was
immediately spun at 3000 g, for 10 min at 4 C. Both samples were
then aliquoted and stored at 80 C for subsequent analysis.
Following this at w0740 h, under local anesthesia (2e3 mL of 1%
Xylocaine (lignocaine)), a w150 mg muscle sample from the vastus
lateralis was obtained under sterile conditions, using a 6 mm Berg-
strom needle modiﬁed with suction, and immediately frozen using
liquid nitrogen before being stored at 80 C for later analysis. Par-
ticipants were provided with breakfast to be consumed within
30 min of 0800 h, before leaving the laboratory with their lunch (also
provided) to be consumed within 30 min of 1300 h. Participants
returned to the laboratory atw1830 h and then consumed an evening
meal. Participants then underwent a forearm venipuncture and muscle
biopsy sampling, as per the morning visit. On each day of measure-
ment, morning and evening biopsies were obtained from the same leg.
All pre-packaged food and ﬂuid for the experimental condition was
then provided to participants for the ﬁrst experimental diet (Day 1e4).
On Day 5, Participants arrived in the lab at w0630 h after a 10 h
overnight fast and following four days of the dietary experimental
condition. All procedures were completed as per Day 0, including a
forearm venipuncture, muscle biopsy sample, breakfast consumption
and provision of lunch meal. Participants returned at w1830 h and,
following the evening meal, a 11 mL blood sample and a muscle bi-
opsy sample were obtained (w1930 h). Following a 7-day washout,
the procedure from Day 7 to Day 5 was repeated with the second
dietary condition. Activity patterns were assessed using several activity
monitors (ActivPAL3TM tri-axial physical activity monitor, PAL-
technologies Ltd, Glasgow, Scotland; ActiGraph GTX3þ accelerom-
eter, Pensacola, FL, USA [waking hours only]; SenseWear armband
(SWA) Bodymedia, Pittsburgh, PA, USA) worn continuously throughout
the baseline and experimental periods of each condition (i.e. 12 d).
2.2.2. Dietary control and adherence
Full detail of the dietary intervention can be found elsewhere [20].
Brieﬂy, habitual intake was monitored for 7-d prior to each dietary
intervention. On Day 0, participants were provided with meals matched
with each participant’s recorded ‘habitual’ intake while total energy
intake provided was according to their baseline resting metabolic rateess article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). 3
Figure 2: Time-of-day-speciﬁc impact of nutritional challenges on human serummetabolome. (A) Histograms exhibit the number of signiﬁcantly increased or decreased serummetabolites
by HFD (pink bar) and HCD (green bar) in themorning (top) and evening (bottom). (BeE) Venn diagrams show the overlap of the number of increased serummetabolites by HFD (B), decreased
serum metabolites by HFD (C), increased serum metabolites by HCD (D), and decreased serum metabolites by HCD (E) between morning and evening. Pie charts exhibit the biological
classiﬁcations of serum metabolites exclusively altered in the morning (left), evening (right) and common to morning and evening (middle). Numbers within Venn diagrams and pie charts
indicate number of changedmetabolites. (F) Volcano plots exhibit the signiﬁcance of altered serummetabolite by HFD (pink) and HCD (green) in the morning. The x-axis and y-axis represent
the fold change (post/pre) and signiﬁcance of changed metabolites, respectively. (G) Volcano plots exhibit the signiﬁcance of altered serum metabolite by HFD (pink) and HCD (green) in the
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(RMR)  1.4 activity factor. All food during each of the 5-d dietary
experimental conditions was provided to participants and a daily food
checklist was completed to maximize compliance. Participants were
instructed to consume meals, each of 33.3% TEI, at standardized
times (within 30 min of 0800, 1300 and 1830 h) throughout both
experimental conditions and to abstain from alcohol consumption,
whilst habitual caffeine consumers were instructed to consume and
record caffeine intake (i.e. black coffee/tea during experimental days)
as usual on all days.
2.3. Biochemical analysis
Triglyceride and cholesterol concentrations were analyzed at time of
collection from whole blood using a Cobas b 101 instrument (Roche
Diagnostics Ltd, Basel, Switzerland). Blood glucose concentrations
were determined using an YSI 2900 analyzer (YSI Life Sciences, Yellow
Springs, OH, USA). Plasma insulin, connecting peptide (C-peptide),
tGLP-1, leptin and TNF-alpha concentrations were determined using a
Luminex Analyzer (MAGPIX; Human Metabolic Hormone Magnetic
Bead Panel, EMD Millipore, MA, USA) following manufacturer’s in-
structions and sample preparation. Serum cortisol was determined
using an enzyme-linked immunosorbent assay (ELISA; KA0918,
Abnova Corporation, Tapei, Taiwan).
2.4. Real-time quantitative polymerase chain reaction (Real-time
qPCR) analysis
Skeletal muscle (w25e30 mg) tissue RNA extraction, reverse tran-
scription and real-time PCR was performed for each subject samples
from morning and evening, as previously described [21]. TaqMan-FAM
labeled primer/probes (Applied Biosystems, Carlsbad, CA, USA) for
Brain and Muscle ARNT-Like 1 (Bmal1; Cat No. Hs00154147), D-Box
Binding PAR BZIP Transcription Factor (Dbp; Cat No. Hs00609747),
CD36 (Cat No. Hs00354519), Peroxisome Proliferator Activated
Receptor-delta (Ppard; Cat No. Hs04187066), Peroxisome Proliferator-
Activated Receptor Gamma Coactivator 1-Alpha (Ppargc1a; Cat No.
Hs00173304), Hexokinase 2 (HK2; Cat No. Hs00606086), Pyruvate
Dehydrogenase Kinase 4 (Pdk4; Cat No. Hs01037712), and Pyruvate
Dehyrogenase Phosphatase Catalytic Subunit 1 (Pdp1; Cat No.
Hs01081518) were used in a ﬁnal reaction volume of 20 mL. 18S ri-
bosomal RNA (18S rRNA, Hs99999901_s1) was used as the house-
keeping gene for normalization of gene expression. The relative
amounts of mRNAs were calculated using the relative quantiﬁcation
(DDCT) method.
2.5. Mass spectrometry (MS) for metabolomics analysis
Metabolomics analysis was performed by Metabolon, Inc. (Durham,
NC, USA), as previously described [22]. Both muscle and serum were
methanol extracted and analyzed by ultra-high-performance liquid
chromatography-tandem MS (UPLC-MS/MS; positive mode), UPLC-
MS/MS (negative mode) and gas chromatographyeMS (GCeMS).
The UPLC-MS/MS platform utilized a Waters Acquity UPLC with Waters
UPLC BEH C18-2.1  100 mm, 1.7 mm columns and a ThermoFisher
LTQ MS, which included an electrospray ionization source and a linear
ion-trap mass analyzer. Samples destined for analysis by GCeMS
were dried under vacuum desiccation for a minimum of 18 h prior
to being derivatized using bis(trimethylsilyl) triﬂuoroacetamide. Deriv-
atized samples were separated on a 5% phenyldimethyl siliconeevening. (H) Top 5 serummetabolites exclusively changed byHFD (top) andHCD (bottom) in them
evening. ** and *** indicates P< 0.01 and P< 0.001 between pre and post, x, xx and xxx in
challenges, y, yy, yyy indicate P< 0.05, P< 0.01 and P< 0.001 betweenmorning and evening
levels between pre- and post-nutritional challenges. Adjusted p-value cutoff of 0.05 was used. N
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to 340 C within a 17-min period. All samples were analyzed on a
Thermo-Finnigan Trace DSQ fast-scanning single-quadrupole MS
operated at unit mass resolving power with electron impact ionization
and a 50e750 atomic mass unit scan range. Metabolites were
identiﬁed by automated comparison of the ion features in the experi-
mental samples to a reference library of chemical standard entries that
included retention time, molecular weight (m/z), preferred adducts,
and in-source fragments as well as associated MS spectra and were
curated by visual inspection for quality control using software devel-
oped at Metabolon, Inc [23].
2.6. Statistical analysis
2.6.1. Gene expression, and blood/plasma biochemical data
Statistical analyses were performed using Prism 5.0. Data from the
two conditions were analyzed using two-way ANOVA, using time and
diet condition as the grouping variable. Subsequent post-hoc com-
parisons between intervention groups were conducted when signiﬁ-
cant based on the Bonferroni test. Signiﬁcance was set at P < 0.05
and data are presented as mean  SEM.
2.6.2. Metabolome data
Untargeted metabolomic data do not follow the normal distribution.
Therefore, we ﬁrst used log transformation before calculating statis-
tical signiﬁcance. We applied False Discovery Rate (FDR) adjustment to
modify the p-value across all metabolites. A metabolite was considered
signiﬁcantly gradient between morning and evening or changed by
nutritional challenges based on an adjusted p-value cutoff of 0.05.
Metabolome data analyses were carried out using R (www.R-project.
org) and Bioconductor (www.bioconductor.org) [24].
3. RESULTS AND DISCUSSION
3.1. Participants and habitual diet analysis
Eight males were randomized and completed both conditions
(Table S1). Habitual dietary analysis showed average intake of
41 4% carbohydrate (including ﬁber), 35 7% fat, 19 2% protein
and 5 8% alcohol across both 7-d periods. Blood proﬁles before and
after nutritional challenges are shown in Fig. S1C. The expression of
core clock and metabolic genes exhibited robust morning-evening
variations (Fig. S1D,E), providing the ﬁrst validation of human serum
and muscle metabolomics under nutritional challenges at different
times of the day. Although the expression of some metabolic genes,
including CD36, Ppard, Hk2 and Pdp1, lost signiﬁcant daily variation
after HFD, we observed marginal effects of diet on daily muscle
metabolic gene expression from pre- to post-nutritional challenge
(Fig. S1D,E). These observations indicate that 5-d nutritional chal-
lenges might not induce robust metabolic response and adaptation at
the levels of transcripts.
3.2. Nutritional challenges impose daily variations in human serum
metabolome
Mass spectrometry (MS) of serum samples detected over 1,000 bio-
chemicals, withw70% of compounds of known identity andw30% of
compounds of unknown structural identity (Figure 1A). More than halforning. (I) Top 5 serummetabolites exclusively changed byHFD (top) andHCD (bottom) in the
dicate P< 0.05, P< 0.01 and P< 0.001 between morning and evening before nutritional
after nutritional challenges. Two-way ANOVA compares themeandifferences ofmetabolites
¼ 8 biological replicates in each time of day were subjected to the metabolomics analysis.
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Figure 3: Nutritional challenges reprogram daily variation of human skeletal muscle metabolome. (A) Number of muscle metabolites affected by diet or time. (B) Separation of
samples based on the diet and collection time by PCA. (C) Heatmaps display signiﬁcantly gradient muscle metabolites exclusively in pre (left panel) and post HFD (middle panel),
and in both pre- and post-HFD (right panel). (D) Pie chart shows the number and ratio of signiﬁcantly gradient metabolites in the muscle under HFD condition. Numbers within the
pie chart indicate number of gradient metabolites. Gradient, metabolites signiﬁcantly different between morning and evening, Morning, metabolites being signiﬁcantly higher in the
morning, and Evening, metabolites being signiﬁcantly higher in the evening. (E) Heatmaps display gradient muscle metabolites exclusively in pre- (left panel) and post-HCD (middle
panel), and in both pre and post HCD (right panel). (F) Pie chart exhibits the number of gradient metabolites in the muscle under HCD treatment. (G) Volcano plot exhibits the
signiﬁcance of gradient muscle metabolites under pre- (open circle) and post- (closed circle) HFD condition. The x-axis and y-axis represent the fold change (evening/morning) and
signiﬁcance of gradient muscle metabolites, respectively. (H) Top 3 gradient muscle metabolites unique to pre-HFD (top) and post-HFD (bottom). ** and *** indicates P < 0.01 and
P < 0.001 between morning and evening, xx indicate P < 0.01 between pre and post in the morning, yyy indicate P < 0.001 between pre and post in the evening. (I) Volcano plot
exhibits the signiﬁcance of gradient muscle metabolites under pre- (open circle) and post- (closed circle) HCD condition. (J) Top 3 gradient muscle metabolites unique to pre-HCD
(top) and post-HCD (bottom). ** and *** indicates P < 0.01 and P < 0.001 between morning and evening, x, xx and xxx indicate P < 0.05, P < 0.01 and P < 0.001 between pre
and post in the morning, yyy indicate P < 0.001 between pre and post in the evening. (K) Histogram shows the biological classiﬁcation of gradient metabolites in the muscle under
HFD (left) and HCD (right) conditions. Orange and blue bars indicate the number of metabolites being higher in the morning and evening, respectively, within each classiﬁcation.
Two-way ANOVA compares the mean differences of metabolites levels between morning and evening. Adjusted p-value cutoff of 0.05 was used. N ¼ 8 biological replicates in each
time of day were subjected to the metabolomics analysis.
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of serum metabolites exhibited time-of-day differences (Figure 1A).
Principal component analysis (PCA) identiﬁed the separation of sam-
ples based on the time of collection between morning and evening in
the serum (Figure 1B).
To establish how a nutritional challenge inﬂuenced the daily variation
of human serum metabolome, we used a two-way ANOVA to compare
the different metabolite levels between morning and evening. The
metabolites exhibiting the daily variation were termed “gradient”
metabolites. The dynamic alteration of gradient serum metabolome
after 5-d HFD and HCD treatments are displayed as heatmaps
(Figure 1C,E, respectively). Following the HFD, w13% of total serum
metabolites lost their daily variation (i.e. did not change between
morning and evening), whilew17% of total serum metabolites gained
a new daily variation (Figure 1D). Most of the gradient metabolites
were those detected to be higher in the evening following dinner,
suggesting the HFD intake directly lead to the reprograming of serum
metabolome (Figure 1D). Following the HCD, w7% of total serum
gradient metabolites lost their oscillatory proﬁle and induced 14% de
novo gradient metabolites (Figure 1F). Similar to the effect of HFD,
most of gradient serum metabolites were those higher in the evening
after the HCD (Figure 1F).
The volcano plot (Figure 1G) supports the reprograming after the HFD,
revealing that a larger number of metabolites were higher in the
evening than the morning, with both greater signiﬁcance and fold
change (Table S2). The most signiﬁcant metabolites that were exclu-
sively gradient after HFD intervention were enriched by the metabolites
related to lipid [10-nonadecenoate (19:1n9), P ¼ 0.00000003; stea-
rate (18:0), P ¼ 0.00000004], in addition to xenobiotics derived from
food components, i.e. organic or natural compounds contained in foods
and as food additives (Figure 1H and Table S2). Given that food intake
functions as an environmental ‘zeitgeber’ for the circadian clock and
circadian control of metabolism [25], it is predictable that the levels of
many serum metabolites are perturbed in response to a nutritional
challenge. These results suggest that the robust alteration of the daily
variation of human serum metabolome by HFD could lead to the
remodeling of clock-controlled metabolic pathway.
Following the HCD, most of the serum gradient metabolites tended to
heighten in the evening and lower in the morning (Figure 1I and
Table S3). b-alanine (P¼ 0.0000006), N1-methylinosine (P¼ 0.00002)
and g-glutamylmethionine (P¼ 0.0003) were unique to gradient serum
metabolites before HCD treatment, while xenobiotics derived from food
components were predominant as the metabolites exclusively gradient
after HCD (Figure 1J and Table S3). This was uniquely observed after
HCD. Plasma metabolites such as glucose and insulin were robustly
altered by the HCD, and not the HFD (Fig. S1C). These divergent re-
sponses highlight the sensitivity of metabolomics for detecting pertur-
bations in body ﬂuids that would otherwise be overlooked by traditional
clinical diagnostic measures, underscoring the sensitivity and reliability
of the analysis.
The biological classiﬁcation of serum gradient metabolites showed an
enrichment of metabolites being higher in the evening after consuming
the dinner meal, within most classiﬁcations both before and after the
HFD intervention (Figure 1K). It was expected that gradient metabolites
related to lipid were likely to be affected by the HFD, especially in the
fed state (i.e. evening). However, the HCD also heightened the number
of gradient metabolites related to lipid metabolism, albeit to a lesser
extent. Therefore, time-of-day-speciﬁc signiﬁcance of lipid type under
nutritional challenges was identiﬁed by scoring the number of me-
tabolites related to lipid within each lipid sub-classiﬁcation (Fig. S2).
Although serum metabolites being higher in the evening after HFD
were enriched with ketone bodies and many types of fatty acid,MOLECULAR METABOLISM 16 (2018) 1e11  2018 The Authors. Published by Elsevier GmbH. This is an open acc
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when fasted after HFD (Fig. S2A). Similar to the observation from the
effect of HFD, ketone bodies and fatty acids gained daily gradient in the
serum after HCD, but with relatively low enrichment rate (Fig. S2B).
These results indicate that both short-term HFD and HCD challenges
inﬂuence daily variations of serum metabolome but providing distinct
metabolic signatures.
3.3. Diverging effects of nutritional challenges on human
metabolome in the morning versus evening
In addition to the time-of-day analysis, we compared the differences of
serum metabolites levels before and after the two divergent dietary
interventions. The levels of w18% and w16% of total serum me-
tabolites were signiﬁcantly changed at morning and evening mea-
sures, respectively, after 5-d of the HFD, whereasw18% andw17%
of total serum metabolites were downregulated by the HCD in the
morning and evening (Figure 2A). Although the proportion of increased
or decreased serum metabolites were similar between morning and
evening, the type of metabolites affected by nutritional challenges
showed a speciﬁc time-of-day difference. The comparison of
increased metabolites by HFD between morning and evening revealed
that 37% of metabolites were exclusively increased in the morning
when fasted and 31% of metabolites were only increased in the
evening when fed, while the number of increased metabolites common
to both morning and evening was only 32% (Figure 2B). However, the
overlap of decreased metabolites by HFD between morning and eve-
ning was <20% (Figure 2C). Similarly, only 25% of increased me-
tabolites overlapped between morning and evening after the HCD
(Figure 2D). Following the HCD, 33% of metabolites were found to be
exclusively decreased in the morning, 31% of metabolites were
decreased only in the evening and only 36% of metabolites were
commonly decreased at both times-of-day (Figure 2E).
To further probe the impact of the time-of-day and diet, the biological
classiﬁcation of serum metabolites changed by nutritional challenges
in the morning versus evening is shown in Figure 2BeE. The HFD
robustly increased the number of metabolites related to lipid meta-
bolism, independent of the time-of-day (Figure 2B). In contrast, about
half of the serum metabolites exclusively decreased in the evening
after HFD were metabolites related to amino acid metabolism
(Figure 2C). In support, reduced circulating amino acids and rates of
skeletal muscle protein synthesis in response to increased fat avail-
ability has been demonstrated using intra-lipid infusions in humans
[26] and from a HFD on selected muscle protein abundance [27]. There
were few metabolites increased after the HCD at either morning or
evening sampling times, but the HCD decreased the number of me-
tabolites related to lipid, without time-of-day preference (Figure 2D,E).
Since metabolites related to lipid seemed to be highly inﬂuenced by
both nutritional challenges, the sub-classiﬁcation of lipid was further
explored. Evening-speciﬁc increase of ketone bodies and variety of
fatty acids was observed after HFD (Fig. S3A), while HFD decreased
metabolites related to carnitine, inositol and mevalonate selectively in
the evening (Fig. S3B). From volcano plots, there was a mild bias
between increased and decreased levels of serum metabolites by HFD
in the morning but not the evening, whereas the HCD decreased the
levels of metabolites both in the morning and evening (Figure 2F,G).
Overall, and as would be expected, most of the serum metabolites
whose levels changed under HFD both in the morning and evening
were metabolites related to lipid metabolism (Tables S4,S5).
To further determine the time-of-day response of serum metabolites
against nutritional challenges, we extracted several serum metabolites
exclusively altered either in the morning or evening after the two differentess article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). 7
Figure 4: Nutritional challenges have distinct impact on human muscle metabolome between morning and evening. (A) Histograms exhibit the number of signiﬁcantly increased or
decreased muscle metabolites by HFD (pink bar) and HCD (green bar) in the morning (top) and evening (bottom). (BeE) Venn diagrams show the overlap of the number of increased
muscle metabolites by HFD (B), decreased muscle metabolites by HFD (C), increased muscle metabolites by HCD (D), and decreased muscle metabolites by HCD (E) between
morning and evening. Pie charts exhibit the biological classiﬁcations of muscle metabolites exclusively altered in the morning (left), evening (right) and common to morning and
Original Article
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diet interventions (Figure 2H,I). Some acylcarnitines [linoleoylcarnitine
(C18:2), P ¼ 0.000001; oleoylcarnitine (C18:1), P ¼ 0.00004; dihomo-
linolenoylcarnitine (C20:2), P ¼ 0.0001)] in the serum were selectively
upregulated by the HFD in the morning (Figure 2H), suggesting that the
HFD lead to a dysfunction of fatty acid b-oxidation and carnitine meta-
bolism through the hyperaccumulation of long-chain fatty acids. The HCD
intake decreased the levels of multiple types of metabolites such as lipid
[trimethylamine N-oxide, P¼ 0.000008; behenate (22:0), P¼ 0.0006],
xenobiotics (4-vinylphenol sulfate, P ¼ 0.000009), amino acid (2-
methylbutyrylcarnitine, P ¼ 0.00002) and carbohydrate (glucuronate,
P ¼ 0.001) in the morning (Figure 2H). Moreover, ketone bodies, b-
hydroxybutyric acid (BHBA, P ¼ 0.0000001) and acetoacetate
(P¼ 0.00003) were dramatically elevated after HFD intake in the evening
(Figure 2I), demonstrating the daily variation of the activity of ketogenesis
in humans after only 5-d exposure to the HFD. Previous studies have
reported that both ketogenic diets (<50 g of carbohydrate per day), along
with high fat and low-carbohydrate diets leads to the circadian oscillation
of serum b-hydroxybutyric acid levels in the mouse [16,28]. The
observation of speciﬁc time-of-day effect of HFD on the levels of human
serum ketone bodies in this intervention is consistent with the obser-
vation from animal studies [16]. In the evening, after the HCD dinner
meal, there was also a decrease of the levels of several metabolites
related primarily to lipid metabolism and to a lesser extent amino acid
(Figure 2I, Fig. S3C,D, and Table S5). The consumption of carbohydrate-
rich meals and the associated rise in plasma insulin concentrations
suppresses lipolysis for several hours post-ingestion [29], and explains
why lipid metabolites were downregulated following the HCD.
3.4. Distinct effect of HFD and HCD on the daily gradient
metabolome of human skeletal muscle
A total of 625 biochemicals (w86% named and w14% unnamed
biochemicals) were detected in skeletal muscle samples (Figure 3A),
with 26% of muscle metabolites affected by the time-of-day
(Figure 3A) compared with w50% of serum metabolites exhibiting
daily variation (Figure 1A). The evening muscle and serum samples
were collected 1 h after the dinner meal and, not surprisingly, the
serum metabolome was more responsive to circulating (blood-borne)
substrate availability than the muscle metabolome. The prevalence of
an interaction (time  trial) effect was similar between serum and
muscle (33% and 24%, respectively; Figures 1A and 3A), demon-
strating that dietary intake functions as a strong zeitgeber for pe-
ripheral clocks in humans. As there was no signiﬁcant separation of
the muscle metabolome between morning and evening by PCA
(Figure 3B), these observations underpin the robust daily variation of
metabolome in the serum rather than skeletal muscle.
Heatmaps display gradient muscle metabolites found exclusively pre-
HFD, post-HFD and common to both measurement times (Figure 3C).
More than 60% of muscle metabolites lost daily variation after the HFD
treatment, while only 19% of metabolites gained a new daily gradient
(Figure 3D). Volcano plots also highlight suppressive impact of the HFD
on the daily variation of muscle metabolome (Figure 3G). Of note, and
in accordance with the serum metabolomics, most of the muscle
metabolites that lost the time-of-day difference after the HFD treatmentevening (middle). Numbers within Venn diagrams and pie charts indicate number of change
HFD (pink) and HCD (green) in the morning. The x-axis and y-axis represent the fold cha
exhibit the signiﬁcance of altered muscle metabolite by HFD (pink) and HCD (green) in t
(bottom) in the morning. (I) Top 5 muscle metabolites exclusively changed by HFD (top) and
and post, x, xx and xxx indicate P < 0.05, P < 0.01 and P < 0.001 between morning a
P < 0.001 between morning and evening after nutritional challenges. Two-way ANOVA c
challenges. Adjusted p-value cutoff of 0.05 was used. N ¼ 8 biological replicates in eac
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metabolites such as BHBA (P ¼ 0.00005), caffeine (P ¼ 0.006) and
glycine (P ¼ 0.01), gained the time-of-day differences after 5-days of
the HFD (Figure 3H and Table S6).
In addition to the effect of HFD, heatmaps show gradient muscle
metabolites pre- HCD, post- HCD, and common to both measurement
days (Figure 3E). However, 136 muscle metabolites gained time-of-
day difference after the HCD (Figure 3F), with almost all of them be-
ing higher in the evening (Figure 3F), which was greater than the
changes to the serum metabolites after HCD. Volcano plots exemplify
the large impact of the HCD on muscle metabolome just after a meal
(Figure 3I). Although some of the metabolites lost daily variation after
the HCD, similar to the serum results, a number of metabolites
prominently related to amino acid (4-hydroxyproline,
P ¼ 0.0000000002; methionine sulfoxide, P ¼ 0.000000002) and
lipid metabolism [stearate (C18:0), P ¼ 0.00000008] gained daily
variation after the HCD (Figure 3J and Table S7).
The analysis of the biological classiﬁcation of gradient muscle me-
tabolites showed that metabolites related to amino acid, peptide,
carbohydrate and lipid metabolism lost daily variation after the HFD
(Figure 3K). In contrast, de novo gradient muscle metabolites after HCD
were seen within almost all biological classiﬁcations, but the most
robust were observed for amino acid and lipid (Figure 3K). In contrast
to the effect of HFD on the serum metabolome (Fig. S2A), muscle
metabolites related to lipid such as phospholipids and fatty acids lost
daily variation after HFD (Fig. S2C). More importantly, metabolites in
the muscle within many of lipid sub-classiﬁcations became higher in
the evening after HCD (Fig. S2D). Thus, both HFD and HCD challenges
led to robust remodeling of the daily variation of the muscle metab-
olome, such that the HFD dampened the daily gradient of the muscle
metabolome while the short-term HCD ampliﬁed the daily gradient of
the muscle metabolome.
3.5. Time-of-day-dependent impact of nutritional challenges on
human muscle metabolome
The HCD decreased the number of muscle metabolites speciﬁcally in
the morning, whereas the HFD intervention had minimal impact on the
muscle metabolome at this time (Figure 4A). The number of muscle
metabolites were greatly increased in the evening by consumption of
the HFD paralleled the HCD (Figure 4A). Comparison of the type of
metabolites altered by nutritional challenges revealed the distinct
impact of nutritional challenges on the muscle metabolome between
morning (fasted) and evening (fed) (Figure 4BeE). Only 25% of me-
tabolites increased by HFD were common to both morning and evening
(Figure 4B). Independent of the time-of-day, metabolites related to lipid
were predominantly increased by the HFD (Figure 4B), showing distinct
types of lipid sub-classiﬁcations between morning and evening
(Fig. S3E). The type of metabolites decreased by HFD were completely
distinguished between morning and evening, and most of the common
metabolites reduced by the HFD were the organic and natural com-
pounds derived from food or plant (Figure 4C and Fig. S3B). The distinct
impact of the HCD on muscle metabolome between morning and
evening was conﬁrmed (Figure 4D,E). The HCD increased the levels ofd metabolites. (F) Volcano plots exhibit the signiﬁcance of altered muscle metabolite by
nge (post/pre) and signiﬁcance of changed metabolites, respectively. (G) Volcano plots
he evening. (H) Top 5 muscle metabolites exclusively changed by HFD (top) and HCD
HCD (bottom) in the evening. ** and *** indicates P < 0.01 and P < 0.001 between pre
nd evening before nutritional challenges, y, yy, yyy indicate P < 0.05, P < 0.01 and
ompares the mean differences of metabolites levels between pre- and post-nutritional
h time of day were subjected to the metabolomics analysis.
ess article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). 9
Original Articlemetabolites related to lipid in the evening and decreased the lipid
metabolites measured in the morning (Figure 4D,E, and Figs. S3G,H,
respectively). Volcano plots illustrate the time-of-day difference of the
effect of nutritional challenges (Figure 4F,G), where metabolites related
to lipids, including phospholipidinositol [PI (18:0/20:4 (5Z, 8Z, 11Z,
14Z)), P ¼ 0.0001] and phospholipidserine [PS (18:0/18:1 (9Z)),
P ¼ 0.001; PS (18:0/18:2), P ¼ 0.002], tended to be increased by HFD
in the morning, while the HCD decreased lipids such as ceramide
(d18:1/20:0, d16:1/22:0, d20:1/18:0) (P¼ 0.0002), phospholipidcoline
[PC (18:0/20:4 (5Z, 8Z, 11Z, 14Z)), P¼ 0.0003] and sphingomyelin [SM
(d18:1/21:0, d17:1/22:0, d16:1/23:0), P ¼ 0.0003] (Figure 4H). Me-
tabolites exclusively altered in the evening by the HFD included BHBA
(P ¼ 0.000003) and acylacarnitines (margaroylcarnitine, P ¼ 0.0002;
stearoylcarnitine, P ¼ 0.0006) (Figure 4I). In contrast to the effect of
HFD, the top ﬁve metabolites exclusively changed in the evening by HCD
were enriched by metabolites related to amino acids (N-methylproline,
P¼ 0.000003; methionine sulfoxide, P¼ 0.000003; S-methylcysteine,
P ¼ 0.00005) (Figure 4I).
3.6. Tissue-speciﬁc metabolomic proﬁles
Examination of the serum metabolome is an expedient approach to
identify metabolic properties related to human diseases and develop
chrono-pharmacological treatments. As such, an understanding of
tissue-speciﬁcity of the human circadian metabolome and how the
serum metabolome may act as a surrogate for peripheral tissue proﬁles
after various interventions is critical. Since the extraction methods for
metabolites and the platform for the detection is different between
serum and muscle metabolome, we compared the enrichment of bio-
logical classiﬁcations between serum and muscle metabolome under
nutritional challenges. The ratio of gradient metabolites related to lipid
metabolism was higher in muscle than serum before nutritional chal-
lenges (i.e. following the participants’ habitual diet; Fig. S4A,B). After a
HFD, serum had newly gradient metabolites related to lipid rather than
amino acid (Fig. S4A) whereas HCD dampened gradient metabolites
related to lipids in muscle (Fig. S4B). The impact of HFD on lipid
metabolism exhibited time-of-day-speciﬁc tissue-dependency where
lipids in the serum and muscle seem to be sensitive to HFD in the
morning and evening, respectively (Fig. S4C). Similar response of lipids
against HCD was observed between serum and muscle regardless of
the time-of-day (Fig. S4D). Of note, gradient and changed metabolites
under nutritional challenges common to both serum and muscle
exhibited a highly similar metabolic adaptation as serum- and muscle-
speciﬁc responses of metabolome (Fig. S4AeD), indicating the possi-
bility of common metabolites detected by both serum and muscle
metabolome as tissue-independent diagnostic markers in human.
Thus, the comparison analysis between serum and muscle metabolome
revealed the synchronicity and heterogeneity of metabolic proﬁles under
nutritional challenges, although further studies must be necessary to
understand tissue-speciﬁcity of human circadian metabolome.
4. CONCLUSION
The past decade of metabolomics studies has been characterized by a
dramatic increase in the quality of the analysis and an increased level of
sophistication of consequent biocomputing tools. Using a combination
of independent platforms and appropriate biocomputing analyses, a
large number of metabolites have been identiﬁed by mass spectrom-
etry and provided previously unappreciated insights into the physiology
of single tissues as well as the degree of metabolic ‘crosstalk’ between
tissues in numerous animal models. However, the application to human
studies is scarce, especially with regard to the impact of various10 MOLECULAR METABOLISM 16 (2018) 1e11  2018 The Authors. Published by Elsevier GmbH. Tnutritional challenges and the timing of meals on the metabolome. The
novel ﬁndings reported here illustrate the changes in metabolomics in
human serum and skeletal muscle in response to nutritional challenges
that are time-of-day dependent. Speciﬁcally, our study shows the
remarkable consistency among the individuals participating in the study
when taking into account their dayenight metabolic proﬁles and re-
sponses to nutritional challenges. Finally, our results demonstrate that
serum metabolomics constitutes an ideal approach towards the
development of precision medicine, where personalized proﬁles would
provide critical information for therapeutic strategies as well as help the
design of appropriate chrono-pharmacological approaches.
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